Who invested in Walking Fish Therapeutics?
Walking Fish Therapeutics's investors include Illumina Ventures and Northpond Ventures.
United States · Series A startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$23Mraised across 1 round since 2022, from 1 source
Source recordedSEC filing: $13M sold, first sale Feb 2022
Walking Fish Therapeutics's investors include Illumina Ventures and Northpond Ventures.
Walking Fish Therapeutics has raised $23M across 1 round since 2022.
Walking Fish Therapeutics's most recent round was a Series A of $23M in Feb 2022.
Its most recent round, $23M in Feb 2022, is also its largest on record.
Walking Fish Therapeutics's first round on record, in Feb 2022, was backed by Illumina Ventures and Northpond Ventures.
Walking Fish Therapeutics's latest named round is a Series A, in Feb 2022.
Walking Fish Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.